The document lists various drug interactions and reactions, including induction or inhibition of cytochrome P450 enzymes, increased risk of digoxin toxicity from certain drugs, competition for albumin-binding sites between some drugs, blood disorders caused by several medications, hemolysis in glucose-6-phosphate dehydrogenase deficient patients, gynecomastia resulting from multiple drugs, Stevens-Johnson syndrome with ethosuximide and sulfonamides, photosensitivity with tetracycline and other drugs, and drug-induced lupus erythematosus from procainamide and other medications.
The document lists various drug interactions and reactions, including induction or inhibition of cytochrome P450 enzymes, increased risk of digoxin toxicity from certain drugs, competition for albumin-binding sites between some drugs, blood disorders caused by several medications, hemolysis in glucose-6-phosphate dehydrogenase deficient patients, gynecomastia resulting from multiple drugs, Stevens-Johnson syndrome with ethosuximide and sulfonamides, photosensitivity with tetracycline and other drugs, and drug-induced lupus erythematosus from procainamide and other medications.
The document lists various drug interactions and reactions, including induction or inhibition of cytochrome P450 enzymes, increased risk of digoxin toxicity from certain drugs, competition for albumin-binding sites between some drugs, blood disorders caused by several medications, hemolysis in glucose-6-phosphate dehydrogenase deficient patients, gynecomastia resulting from multiple drugs, Stevens-Johnson syndrome with ethosuximide and sulfonamides, photosensitivity with tetracycline and other drugs, and drug-induced lupus erythematosus from procainamide and other medications.